Policy Week in Review – May 1, 2026

Why It Matters

A Supreme Court ruling could reshape federal enforcement across agencies, while the retirement and apprenticeship initiatives aim to broaden workforce financial security and skill development. The DEA’s schedule change signals a nuanced federal stance on medical cannabis, and clearer contractor rules could reduce litigation risk for businesses.

Key Takeaways

• Supreme Court to rule on agency monetary penalties without judicial review
• Trump order launches TrumpIRA.gov to broaden retirement options for workers
• Senate introduces ADVICE and START Acts to improve apprenticeship data and speed
• DEA reclassifies FDA‑approved marijuana meds as Schedule III, prescription‑only
• WPI backs DOL two‑step contractor rule for clearer employee classification

Pulse Analysis

The Supreme Court’s willingness to review *Sun Valley Orchards v. Department of Labor* places the nation’s administrative enforcement model under a constitutional microscope. If the high court affirms the lower‑court finding that agency‑run fines violate Article III, dozens of federal programs—from wage‑hour compliance to environmental penalties—could lose a fast‑track enforcement tool, forcing agencies to rely on traditional courts and potentially slowing compliance actions. Legal scholars predict a ripple effect that may prompt Congress to rewrite enforcement statutes to preserve agency authority while respecting judicial oversight.

At the same time, the Trump administration is targeting two persistent gaps in the American labor market. The new TrumpIRA.gov portal promises a one‑stop shop for workers lacking employer‑sponsored retirement plans, expanding access to tax‑advantaged savings and potentially boosting participation rates among the under‑served 30 percent of the workforce. Parallelly, Senate HELP Committee leaders introduced the ADVICE and START Acts, which seek to tighten apprenticeship data reporting and accelerate program approvals, respectively. Together, these measures could create clearer career pathways, improve wage transparency, and help firms fill skilled‑trade vacancies faster.

The DEA’s decision to reclassify FDA‑approved marijuana products as Schedule III marks a calibrated shift in federal drug policy, distinguishing therapeutic compounds from recreational cannabis. By allowing prescription‑only access, the agency acknowledges emerging medical evidence while maintaining broader prohibition. This nuanced approach may encourage pharmaceutical investment in cannabinoid research and provide patients with a regulated supply chain. Meanwhile, Littler’s WPI comments on the Department of Labor’s proposed contractor rule underscore a growing consensus for a streamlined, two‑step test that balances flexibility for gig‑economy workers with legal certainty for employers, a balance that could become a template for future labor‑law reforms.